Doctor profile · Federal record
Dr. PETER BERCZ, M.D.
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · Critical Care Medicine (Internal Medicine) Physician · Pulmonary Disease Physician · PENSACOLA, FL
- NPI 1275725178
- Accepts Medicare
- MIPS 14.8 / 100 · 2023
- 28 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4700 BAYOU BLVD, STE 6
PENSACOLA, FL 325031901
(850) 477-9253
fax (850) 494-9843
Credentials & registration
- NPI registered
- August 2007 — 19 yrs on file
- Profile last updated
- June 6, 2017
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (2)
- Florida #ME113259 · Pennsylvania #MD432552
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275725178. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,904
Distinct HCPCS
10
Medicare allowed
$371,837
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 797 | 293 | $118 | |
99291 |
Critical care, first 30-74 minutes | 421 | 213 | $214 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 342 | 261 | $124 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 314 | 235 | $172 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 254 | 140 | $78 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 136 | 128 | $170 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 73 | 69 | $37 | |
94729 |
Test to examine how well the lungs exchange gases | 73 | 69 | $52 | |
94726 |
Test to determine lung volumes using sensors | 65 | 62 | $51 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 60 | 60 | $217 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 121. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$1,317
Transactions
56
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $208.55 | |
| JAZZ PHARMACEUTICALS INC. | 4 | $191.27 | |
| Regeneron Healthcare Solutions, Inc. | 7 | $130.89 | |
| GENZYME CORPORATION | 4 | $94.98 | |
| Electromed, Inc. | 9 | $93.93 | |
| Mylan Specialty L.P. | 4 | $93.47 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72.14 | |
| GlaxoSmithKline, LLC. | 4 | $65.16 | |
| Amgen Inc. | 2 | $54.28 | |
| Inspire Medical Systems, Inc. | 2 | $47.81 | |
| Philips North America LLC | 2 | $44.69 | |
| Insmed, Inc. | 2 | $43.07 | |
| Axsome Therapeutics, Inc. | 2 | $34.85 | |
| United Therapeutics Corporation | 2 | $34.56 | |
| Genentech USA, Inc. | 2 | $33.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
636
Patients
141
Total drug cost
$250,211
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 115 | 41 | $3,938 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 63 | 0 | $37,652 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 61 | 18 | $66,068 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 50 | 15 | $35,128 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 47 | 15 | $4,815 |
| Montelukast Sodium | Generic | 45 | 12 | $770 |
| Azithromycin | Generic | 42 | 17 | $1,327 |
| Prednisone | Generic | 40 | 23 | $178 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | Brand | 36 | 0 | $24,928 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 35 | 0 | $30,223 |